101 related articles for article (PubMed ID: 1241259)
1. [Farnesol and neuroleptics. II. Action of farnesol, alone or associated with a neuroleptic, on the stereotypies induced in the rat by amphetamine].
Binet P; Miocque M; Roux M; Rinjard P
Ann Pharm Fr; 1975; 33(6-7):321-8. PubMed ID: 1241259
[No Abstract] [Full Text] [Related]
2. The effect of certain drugs on amphetamine-induced stereotyped behavior and brain amphetamine levels in the rat.
Lal S; Missala K; Sourkes TL; Feldmuller F
Biol Psychiatry; 1974 Aug; 9(1):3-10. PubMed ID: 4156181
[No Abstract] [Full Text] [Related]
3. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
4. Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice.
Lal H; Marky M; Fielding S
Neuropharmacology; 1976 Nov; 15(11):669-71. PubMed ID: 1034243
[No Abstract] [Full Text] [Related]
5. Neuroleptics attentuate stereotyped behavior induced by beta-phenylethylamine in rats.
Moja EA; Stoff DM; Gillin JC; Wyatt RJ
Biol Psychiatry; 1978 Apr; 13(2):291-5. PubMed ID: 566570
[No Abstract] [Full Text] [Related]
6. [Farnesol and neuroleptics. I. Reinforcement by farnesol of the experimental cataleptigenic effect of neuroleptics].
Binet P; Miocque M; Roux M; Rinjard P
Ann Pharm Fr; 1975 May; 33(5):229-34. PubMed ID: 1239975
[No Abstract] [Full Text] [Related]
7. [Effect of neuroleptics, midantan and DOPA on apomorphine sterotypy in rats].
Kalinin VV
Farmakol Toksikol; 1977; 40(1):16-9. PubMed ID: 558110
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system.
Muller P; Seeman P
J Pharm Pharmacol; 1974 Dec; 26(12):981-4. PubMed ID: 4156868
[No Abstract] [Full Text] [Related]
9. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Lemberger L; Kellams JJ; Small JG; Rowe H
Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
[No Abstract] [Full Text] [Related]
10. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
Kostowski W; Czlonkowski A
Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
[No Abstract] [Full Text] [Related]
11. MJ 9022: correlation between neuroleptic potential and stereotypy.
Sathananthan GL; Sanghvi I; Phillips N; Gershon S
Curr Ther Res Clin Exp; 1975 Nov; 18(5):701-5. PubMed ID: 1208
[No Abstract] [Full Text] [Related]
12. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
[No Abstract] [Full Text] [Related]
13. Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain.
Rollema H; Westerink BH; Grol CJ
J Pharm Pharmacol; 1976 Apr; 28(4):321-3. PubMed ID: 6728
[No Abstract] [Full Text] [Related]
14. Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies.
Fowler SC; Birkestrand B; Chen R; Vorontsova E; Zarcone T
Psychopharmacology (Berl); 2003 Nov; 170(2):167-77. PubMed ID: 12827349
[TBL] [Abstract][Full Text] [Related]
15. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
Smith RC; Davis JM
Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and physiology of stereotyped behavior.
Randrup A; Munkvad I
J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
[No Abstract] [Full Text] [Related]
17. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
Humber LG; Bruderlein FT; Voith K
Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
[No Abstract] [Full Text] [Related]
18. The mechanism of action of psychopharmacological agents on behaviour.
Munkvad I
Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 2):21-30. PubMed ID: 805510
[No Abstract] [Full Text] [Related]
19. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
Gale KN; Murray JP; Horita A
Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
[No Abstract] [Full Text] [Related]
20. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances.
Sikiric P; Jelovac N; Jelovac-Gjeldum A; Dodig G; Staresinic M; Anic T; Zoricic I; Rak D; Perovic D; Aralica G; Buljat G; Prkacin I; Lovric-Bencic M; Separovic J; Seiwerth S; Rucman R; Petek M; Turkovic B; Ziger T; Boban-Blagaic A; Bedekovic V; Tonkic A; Babic S
Acta Pharmacol Sin; 2002 May; 23(5):412-22. PubMed ID: 11978191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
